Home
Conditions
Acute Lymphoblastic Leukemia

Clinical trial condition

Acute Lymphoblastic Leukemia

Explore clinical trials studying Acute Lymphoblastic Leukemia. Study availability and eligibility vary by location and protocol.

471 public trials 116 recruiting studies

Refine in advanced search Browse all conditions

Acute Lymphoblastic Leukemia trial results

Not Yet Recruiting

Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase

NCT07320534

Conditions: Acute Lymphoblastic Leukemia, Agranulocytosis, Cytopenia, +16 more
Locations: RSUP dr Sardjito Sleman, DI Yogyakarta, Indonesia

View Trial Details

Not Yet Recruiting

BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia Patients

NCT07301138

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations: Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

ALL Backbone in AYAs

NCT07227584

Conditions: Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia (ALL), Hematologic Diseases, +11 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

NCT07175415

Conditions: Acute Lymphoblastic Leukemia, Disease Attributes, Hematologic Diseases, +19 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase I Clinical Trial of RS001 in Patients with Relapsed/Refractory B-Cell Malignancies

NCT06894693

Conditions: Acute Lymphoblastic Leukemia, B-cell Non-Hodgkin's Lymphoma, Hematologic Diseases, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for Newly Diagnosed B-cell ALL Patients in CR1

NCT06777264

Conditions: Acute Lymphoblastic Leukemia, B Cell ALL, Burkitt Lymphoma, +20 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Systemic Inflammation Response Index and C-Reactive Protein to Albumin Ratio in Acute Lymphoblastic Leukemia

NCT06674850

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Coagulopathy in Childhood Acute Lymphoblastic Leukaemia

NCT06242353

Conditions: Acute Lymphoblastic Leukemia, Bleeding, Cardiovascular Diseases, +20 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase 1b-2 Trial to Assess Venetoclax and Navitoclax Consolidation and Post-transplant Maintenance in High-risk Patients With T-ALL

NCT05054465

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Soroka Medical Center Beersheba, Israel

Rambam Health Care Campus Haifa, Israel

Shaare Zedek Medical Center Jerusalem, Israel

Rabin Medical Center Petah Tikva, Israel

View Trial Details

Completed

CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)

NCT01134575

Conditions: Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +23 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia trial results

Related conditions